AtriCure (ATRC) Tops Q4 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $59.30 +2.83%
EPS Growth %: -300.0%
Financial Fact:
Income tax expense (benefit): 2K
Today's EPS Names:
PBCO, SICP, MNSB, More
EPS Growth %: -300.0%
Financial Fact:
Income tax expense (benefit): 2K
Today's EPS Names:
PBCO, SICP, MNSB, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.09), $0.09 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $88 million versus the consensus estimate of $87.77 million.
GUIDANCE:
AtriCure sees FY2023 revenue of $380-387 million, versus the consensus of $381.7 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bloom Energy shares fall despite beating Q3 estimates
- MaxLinear (MXL) Tops Q3 EPS by 6c; Offers Outlook
- Eastern Bankshares (EBC) Tops Q3 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
